Barely Significant
← all excerpts

Bremelanotide for Treatment of Female Hypoactive Sexual Desire.

Neurol Int · 2022 · PMC8788464 · PMID 35076581

Europe PMCDOI
1
hedged sentence
0.7640
closest p · 15.3× alpha
0.7640
boldest claim

The sentences

did not reach statistical significancep = 0.764not close (p > 0.1)
The change between the baseline and end-of-study number of satisfying sexual events reported did not reach statistical significance between the treatment groups (study 301 bremelanotide 0.0, placebo −0.1 p = 0.764, study 302 bremelanotide 0.0, placebo 0.0 p = 0.702, integrated studies bremelanotide 0.0, placebo −0.1 p = 0.630).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.